Article Versions Notes

Świątek Ł, Miedziaszczyk M, Lewandowski D, Robakowski F, Tyburski P, Jakubowska M, Karczewski M, Idasiak-Piechocka I. The Promising Effect of Tocilizumab on Chronic Antibody-Mediated Rejection (cAMR) of Kidney Transplant. Pharmaceutics. 2025; 17(1):78. https://doi.org/10.3390/pharmaceutics17010078

Świątek, Łukasz, Miłosz Miedziaszczyk, Dominik Lewandowski, Filip Robakowski, Piotr Tyburski, Marta Jakubowska, Marek Karczewski, and Ilona Idasiak-Piechocka. 2025. "The Promising Effect of Tocilizumab on Chronic Antibody-Mediated Rejection (cAMR) of Kidney Transplant" Pharmaceutics 17, no. 1: 78. https://doi.org/10.3390/pharmaceutics17010078

Świątek, Ł., Miedziaszczyk, M., Lewandowski, D., Robakowski, F., Tyburski, P., Jakubowska, M., Karczewski, M., & Idasiak-Piechocka, I. (2025). The Promising Effect of Tocilizumab on Chronic Antibody-Mediated Rejection (cAMR) of Kidney Transplant. Pharmaceutics, 17(1), 78. https://doi.org/10.3390/pharmaceutics17010078